Dermatomyositis and Urticaria

Summary:

Urticaria is found among people with Dermatomyositis, especially for people who are female, 50-59 old.

The study analyzes which people have Urticaria with Dermatomyositis. It is created by eHealthMe based on reports of 87 people who have Dermatomyositis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatomyositis?

Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer) is found to be associated with 262 drugs and 416 conditions by eHealthMe. Check the latest studies of Dermatomyositis.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,612 drugs and 2,955 conditions by eHealthMe. Check the latest studies of Urticaria.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

87 people who have Dermatomyositis and Urticaria are studied.

Would you have Urticaria when you have Dermatomyositis?

Gender of people who have Dermatomyositis and experienced Urticaria *:

female: 78.05 %
male: 21.95 %

Age of people who have Dermatomyositis and experienced Urticaria *:

Common co-existing conditions for these people *:

Herpes Simplex (herpes simplex is a common viral infection): 3 people, 3.45%
Uveitis (inflammation of the uvea): 1 person, 1.15%
Tinea Infection (fungal skin infection): 1 person, 1.15%
Athlete's Foot (a fungal infection affecting the skin between the toes): 1 person, 1.15%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 1.15%
Chronic Infantile Neurological Cutaneous And Articular Syndrome (a rare genetic periodic fever with joints inflammation): 1 person, 1.15%
Chronic Recurrent Multifocal Osteomyelitis (rare condition (1:1,000,000), in which the bones have lesions, infection, and pain): 1 person, 1.15%
Familial Mediterranean Fever (genetic disease recurring attacks of abdominal pain, fever, pleurisy, arthritis, and rash): 1 person, 1.15%
Folliculitis (infection of hair root): 1 person, 1.15%
Fungal Infection: 1 person, 1.15%

Common drugs taken by these people *:

Common symptoms for these people *:

Itching: 43 people, 49.43%
Rashes (redness): 20 people, 22.99%
Infusion Related Reaction: 10 people, 11.49%
Headache (pain in head): 7 people, 8.05%
Rash Pruritic (redness with itching): 7 people, 8.05%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 6 people, 6.90%
Hypersensitivity: 6 people, 6.90%
Nausea (feeling of having an urge to vomit): 5 people, 5.75%
Pain: 5 people, 5.75%
Infusion Site Erythema (reddening of the skin at infusion site): 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition

Related publications that referenced our studies

Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

Related studies:

Treatments, associated drugs and conditions:

Dermatomyositis (8,399 reports)
Urticaria (173,777 reports)

All the drugs that are associated with Urticaria:

Urticaria (2,612 drugs)

All the conditions that are associated with Urticaria:

Urticaria (2,955 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Urticaria and Dermatomyositis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.